Development and Adaptation of I-STRONG for SCD
NCT06110754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2025-12-19
Summary
This study develops and tests the feasibility and acceptability of an adapted intervention, Integrative Strong Body and Mind Training (I-STRONG), in adolescents with pain from sickle cell disease.
Conditions
Interventions
- BEHAVIORAL
-
I-STRONG for SCD
I-STRONG for SCD is a group-based, multi-component intervention that includes mind-body, cognitive-behavioral, and neuromuscular movement training. The intervention includes 16 sessions that occur over 8 weeks. Adolescents attend every session and parents attend 6 of the 16 sessions.
Sponsors & Collaborators
-
National Center for Complementary and Integrative Health (NCCIH)
collaborator NIH -
Emory University
lead OTHER
Principal Investigators
-
Soumitri Sil, PhD · Emory University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-08
- Primary Completion
- 2024-06-14
- Completion
- 2024-06-14
Countries
- United States
Study Locations
More Related Trials
-
Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Sickle Cell Disease
NCT04877054 ·Status: COMPLETED ·Phase: NA
-
Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain
NCT01058473 ·Status: COMPLETED
-
Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA)
NCT04181944 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Pro-Inflammatory Response to Interval Training Study
NCT03653676 ·Status: COMPLETED
-
Pressure Pain Tolerance in Relation to Balance and Strength in Children
NCT06529874 ·Status: RECRUITING ·Phase: NA
-
Low Systemic/High Local Exercise Load in Peds SCD
NCT06387758 ·Status: RECRUITING ·Phase: NA
-
Feasibility of a Stress Reduction Intervention Study in Sickle Cell Disease
NCT02501447 ·Status: COMPLETED ·Phase: NA
-
Improving Self-Management in Adolescents With Sickle Cell Disease
NCT02851615 ·Status: COMPLETED ·Phase: NA
-
Predictors of Pain in Sickle Cell Disease
NCT06139510 ·Status: RECRUITING ·Phase: NA
-
Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease
NCT01369160 ·Status: COMPLETED
-
Exercise Capacity in Pediatric Sickle Cell Anemia
NCT01527799 ·Status: COMPLETED
-
MBSR for Pain Catastrophizing in SCD
NCT02394587 ·Status: COMPLETED ·Phase: NA
-
Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study
NCT04156399 ·Status: TERMINATED ·Phase: NA
-
Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients
NCT02571088 ·Status: COMPLETED ·Phase: NA
-
Pain Management Protocol for Pediatric Sickle Cell Disease
NCT00386048 ·Status: COMPLETED
-
Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease
NCT02987725 ·Status: COMPLETED ·Phase: NA
-
Parent Educational Program for Children With Sickle Cell Disease
NCT00860782 ·Status: COMPLETED ·Phase: NA
-
Near Infrared Spectroscopy in Sickle Cell Pediatric Patients
NCT04031521 ·Status: WITHDRAWN
-
Genetics and Pain Severity in Sickle Cell Disease
NCT01441141 ·Status: COMPLETED
-
Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease
NCT02200510 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
NCT01558076 ·Status: COMPLETED
-
A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
NCT00895154 ·Status: COMPLETED ·Phase: NA
-
Cooperative Study of The Clinical Course of Sickle Cell Disease
NCT00005277 ·Status: COMPLETED
-
Pain in Sickle Cell Epidemiologic Study
NCT00035763 ·Status: COMPLETED
-
Utilizing A Single Session Problem-Solving Intervention With Caregivers of Pediatric Patients Receiving Chronic Transfusion to Treat Sickle Cell Disease
NCT04606160 ·Status: COMPLETED ·Phase: NA